NCT01390883View on ClinicalTrials.gov

Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)

CompletedOBSERVATIONAL

Enrollment

475

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Cardiovascular Disease

Interventions

DRUG

Fondaparinux Sodium

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY